AnnJi

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.ajpharm.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2014

AnnJi Pharmaceutical develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy.

Its portfolio also includes AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis. Founded in 2014, AnnJi Pharmaceutical is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$31.50NT$71.20

Beta-0.39

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-3.78

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.